According to The Washington Post, the White House is preparing to replace FDA Commissioner Marty Makary. The agency has been rocked by internal turmoil in recent months, with several policy decisions sparking controversy and eroding public trust. Makary’s reform agenda has drawn intense debate from both the scientific community and political circles.

Analysts suggest this leadership change could further impact the FDA’s regulatory direction and policy continuity.

Source: The Washington Post

The White House is preparing to replace FDA Commissioner Marty Makary, according to The Washington Post. President Trump has signed off on the ouster, senior officials confirmed. Makary’s tenure has been marked by internal policy disputes and personnel turmoil at the agency. The leadership change signals a potential shift in the FDA’s regulatory direction.

Source: The Washington Post, Google News